Literature DB >> 23041752

Association of left ventricular motion and central augmentation index in healthy young men.

Kevin Cheng1, James D Cameron, Matthew Tung, Philip M Mottram, Ian T Meredith, Sarah A Hope.   

Abstract

BACKGROUND: Central blood pressure is a determinant of cardiovascular outcome; however, it can be described by parameters other than systolic and diastolic pressure with central augmentation index (AIx) often utilized. Although generally considered as determined by peripheral pressure wave reflection, not all data are consistent with this interpretation of AIx. We hypothesized that the motion of the heart during systole may influence central pressure waveform morphology, including the AIx.
METHOD: We studied the carotid pressure waveform, aortic stiffness and endothelial function in 20 healthy young men (full data available in 19). Arterial stiffness was measured by carotid femoral pulse wave velocity (cfPWV), endothelial function by peripheral arterial plethysmography (PAPl) and central blood pressure waveform by carotid applanation tonometry. Basal cardiac motion was assessed with pulsed wave tissue Doppler imaging of the septal mitral annulus.
RESULTS: Carotid AIx decreased after the administration of glyceryl trinitrate by 11.3 ± (sem) 4.6% (P = 0.02); however, time to the inflection point (Ti) did not change. During systolic contraction at both baseline and after glyceryl trinitrate, time to peak annular systolic velocity was directly related to, and always preceded, carotid Ti (R(2) = 0.81; P < 0.01). Carotid Ti and AIx were not related to cfPWV or endothelial function.
CONCLUSION: In fit young men, rather than only being a consequence of arterial properties Ti, and therefore central AIx, may be substantially determined by left ventricular systolic function. These findings question the interpretation of central AIx as a measure of pressure wave reflection and aortic stiffness and potentially impact its interpretation in diagnosis and treatment of cardiovascular risk.

Entities:  

Mesh:

Year:  2012        PMID: 23041752     DOI: 10.1097/HJH.0b013e328358bee2

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Does Measurement of Central Blood Pressure have Treatment Consequences in the Clinical Praxis?

Authors:  Gary F Mitchell
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 2.  Pulse Waveform Analysis: Is It Ready for Prime Time?

Authors:  Bernhard Hametner; Siegfried Wassertheurer
Journal:  Curr Hypertens Rep       Date:  2017-08-11       Impact factor: 5.369

3.  Reservoir pressure analysis of aortic blood pressure: an in-vivo study at five locations in humans.

Authors:  Om Narayan; Kim H Parker; Justin E Davies; Alun D Hughes; Ian T Meredith; James D Cameron
Journal:  J Hypertens       Date:  2017-10       Impact factor: 4.844

4.  Associations and clinical relevance of aortic-brachial artery stiffness mismatch, aortic reservoir function, and central pressure augmentation.

Authors:  Martin G Schultz; Alun D Hughes; Justin E Davies; James E Sharman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-14       Impact factor: 4.733

5.  Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial.

Authors:  Kirthi Menon; James D Cameron; Maximilian de Courten; Barbora de Courten
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

6.  Left ventricular long axis tissue Doppler systolic velocity is independently related to heart rate and body size.

Authors:  Roger E Peverill; Bon Chou; Lesley Donelan
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

7.  Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial.

Authors:  Estifanos Baye; Kirthi Menon; Maximilian Pj de Courten; Arul Earnest; James Cameron; Barbora de Courten
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.